Neurobiology of Suicide

Handbook of Medical Psychiatry

Volumn , Issue , 2003, Pages 701-712

  Sher, Leo ^a   Mann, J John ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85143469943     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.3109/9780203912485-52     Document Type: Chapter

References (120)

1. Maris RW, Berman AL, Silverman MM. Comprehensive Textbook of Suicidology. New York: Guilford Press, 2000.
2. Ghosh TB, Victor BS. Suicide. In: Hales RE, Yudofsky SC, Talbott JA, eds. The American Psychiatric Press Textbook of Psychiatry, 3rd ed. Washington: American Psychiatric Press, 1999, pp 1383-1404.
3. Mann JJ. The neurobiology of suicide. Nat Med 4:25-30, 1998.
4. Suominen K, Henriksson M, Suokas J, Isometsa E, Ostamo A, Lonnqvist J. Mental disorders and comorbidity in attempted suicide. Acta Psychiatr Scand 94: 234-240, 1996.
5. Barraclough B, Bunch J, Nelson B, Sainsbury P. One hundred cases of suicide. Clinical aspects. Br J Psychiatry 125:355-373, 1974.
6. Robins E, Murphy GE, Wilkinson RH Jr, Gassner S, Kayes J. Some clinical considerations in the prevention of suicide based on a study of 134 successful suicides. Am J Public Health 49:888-899, 1979.
7. Rich CL, Fowler RC, Wagner J, Black NA. San Diego suicide study. III. Relationships between diagnoses and stressors. Arch Gen Psychiatry 45:58-592, 1988.
8. Dorpat TL, Ripley HS. A study of suicide in the Seattle area. Compr Psychiatry 1:349-359, 1960.
9. Isometsa E, Henriksson M, Aro H, Heikkinen M, Kuoppasalmi K, Lonnqvist J. Mental disorders in young and middle aged men who commit suicide. BMJ 310:1366-1367, 1995.
10. Jamison KR. Suicide and bipolar disorders. Ann NY Acad Sci 487:301-315, 1986.
11. Johns CA, Stanley M, Stanley B. Suicide in schizophrenia. Ann NY Acad Sci 487:294-300, 1986.
12. Roy A, Linnoila M. Alcoholism and suicide. Suicide Life Threat Behav 16:244-273, 1986.
13. Frances A, Fyer M, Clarkin J. Personality and suicide. Ann NY Acad Sci 487:281-293, 1986.
14. Roy A, Lamparski J, De Jong J, Karoum F, Linnoila M. Cerebrospinal fluid monoamine metabolites in alcoholic patients who attempt suicide. Acta Psychiatr Scand 81:58-61, 1990.
15. Roy A, Lamparski J, De Jong J, Moore V, Linnoila M. Characteristics of alcoholics who attempt suicide. Am J Psychiatry 147:761-765, 1990.
16. Murphy GE. Suicide and substance abuse. Arch Gen Psychiatry 45:593-594, 1988.
17. Murphy GE, Wetzel RD, Robins E, McEvoy L. Multiple risk factors predict suicide in alcoholism. Arch Gen Psychiatry 49:459-463, 1992.
18. Dulit RA, Fyer MR, Haas GL, Sullivan T, Frances AJ. Substance use in borderline personality disorder. Am J Psychiatry 147:1002-1007, 1990.
19. Marzuk PM, Mann JJ. Suicide and substance abuse. Psychiat Ann 18:639-645, 1988.
20. Brent DA. Overrepresentation of epileptics in a consecutive series of suicide attempters seen at a Children’s Hospital, 1978-1983. J Am Acad Child Psychiatry 25(2):242-246, 1986.
21. Schoenfeld M, Myers RH, Cupples LA, Berkman B, Sax DS, Clark E. Increased rate of suicide among patients with Huntington’s disease. J Neurol Neurosurg Psychiatry 47:1283-1287, 1984.
22. Farrer LA. Suicide and attempted suicide in Huntington disease: implications for preclinical testing of persons at risk. Am J Med Genet 24:305-311, 1986.
23. Bostwick JM, Pankratz VS. Affective disorders and suicide risk: a reexamination. Am J Psychiatry 157:1925-1932, 2000.
24. Murphy GE, Wetzel R. The lifetime risk of suicide in alcoholism. Arch Gen Psychiatry 47:383-392, 1990.
25. Malone KM, Haas GL, Sweeney JA, Mann JJ. Major depression and the risk of attempted suicide. J Affect Disord 34:173-185, 1995.
26. Roy A, Segal Segal NL, Centerwall BS, Robinette CD. Suicide in twins. Arch Gen Psychiatry 48:29-32, 1991.
27. Roy A, Segal NL, Sarchiapone M. Attempted suicide among living co-twins of twin suicide victims. Am J Psychiatry 152:1075-1076, 1995.
28. Schulsinger F, Kety SS, Rosenthal D, Wender PH. A family study of suicide. In: Schou M, Stromgren E, eds. Origin, Prevention and Treatment of Affective Disorders. New York: Academic Press, 1979.
29. Brodsky BS, Malone KM, Ellis SP, Dulit RA, Mann JJ. Characteristics of borderline personality disorder associated with suicidal behavior. Am J Psychiatry 154:1715-1719, 1997.
30. Breslau N. Migraine, suicidal ideation, and suicide attempts. Neurology 42:392-395, 1992.
31. Breslau N, Davis GC, Andreski P. Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res 37:11-23, 1991.
32. Muldoon MF, Manuck SB, Matthews KA. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. BMJ 301:309-314, 1990.
33. Muldoon MF, Rossouw JE, Manuck SB, Glueck CJ, Kaplan JR, Kaufmann PG. Low or lowered cholesterol and risk of death from suicide and trauma. Metabolism 42(suppl 1):45-56, 1993.
34. Kaplan JR, Muldoon MF, Manuck SB, Mann JJ. Assessing the observed relationship between low cholesterol and violence-related mortality. Implications for suicide risk. Ann NY Acad Sci 836:57-80, 1997.
35. Kaplan JR, Shively CA, Fontenot MB, Morgan TM, Howell SM, Manuck SB, Muldoon MF, Mann JJ. Demonstration of an association among dietary cholesterol, central serotonergic activity, and social behavior in monkeys. Psychosom Med 56:479-484, 1994.
36. Lindberg G, Larsson G, Setterlind S, Rastam L. Serum lipids and mood in working men and women in Sweden. J Epidemiol Community Health 48:360363, 1994.
37. Golomb BA. Cholesterol and violence: is there a connection? Ann Intern Med 128:478-87, 1998.
38. Neaton JD, Blackburn H, Jacobs D, Kuller L, Lee DJ, Sherwin R, Shih J, Stamler J, Wentworth D. Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Arch Intern Med 152:1490-500, 1992.
39. Kunugi H, Takei N, Aoki H, Nanko S. Low serum cholesterol in suicide attempters. Biol Psychiatry 41:196-200, 1997.
40. Mann JJ, Arango V. Integration of neurobiology and psychopathology in a unified model of suicidal behavior. J Clin Psychopharmacol 12(2):2S-7S, 1992.
41. Burton R. The Anatomy of Melancholy. London: JM Dent & Sons, 1932.
42. Roy A. Genetics of suicide. Ann NY Acad Sci 487:97-105, 1986.
43. Roy A. Genetic and biologic risk factors for suicide in depressive disorders. Psychiatr Q 64(4):345-358, 1993.
44. Brent DA, Bridge J, Johnson BA, Connolly J. Suicidal behavior runs in families. A controlled family study of adolescent suicide victims. Arch Gen Psychiatry 53:1145-1152, 1996.
45. Murphy GE, Wetzel RD. Family history of suicidal behavior among suicide attempters. J Nerv Ment Dis 170:86-90, 1982.
46. Roy A. Family history of suicide. Arch Gen Psychiatry 40:971-974, 1983.
47. Egeland JA, Sussex JN. Suicide and family loading for affective disorders. JAMA 254:915-918, 1985.
48. Shafii M, Carrigan S, Whittinghill JR, Derrick A. Psychological autopsy of completed suicide in children and adolescents. Am J Psychiatry 142(9):1061-1064, 1985.
49. Linkowski P, De Maertelaer V, Mendlewicz J. Suicidal behaviour in major depressive illness. Acta Psychiatr Scand 72:233-238, 1985.
50. Statham DJ, Heath AC, Madden PA, Bucholz KK, Bierut L, Dinwiddie SH, Slutske WS, Dunne MP, Martin NG. Suicidal behaviour: an epidemiological and genetic study. Psychol Med 28:839-855, 1998.
51. Wender PH, Kety SS, Rosenthal D, Schulsinger F, Ortmann J, Lunde I. Psychiatric disorders in the biological and adoptive families of adopted individuals with affective disorders. Arch Gen Psychiatry 1986; 43:923-9, 1986.
52. Lathrop GM, Terwilliger JD, Weeks DE. Multifactorial inheritance and genetic analysis of multifactorial disease. In: Rimoin DL, Connor JM, Pyeritz RE, eds. Emery and Rimon’s Principle and Practice of Medical Genetics. 3rd ed. New York: Churchill Livingstone, 1996, pp. 1765-1770.
53. Eley TC, Plomin R. Genetic analyses of emotionality. Curr Opin Neurobiol 7:279-284, 1997.
54. Gelertner J. Clinical molecular genetics. In: Charney DS, Nestler EJ, Bunney BS, eds. Neurobiology of Mental Ilness. New York: Oxford University Press, 1999, pp 108-120.
55. Cravchik A, Goldman D. Neurochemical individuality: genetic diversity among human dopamine and serotonin receptors and transporters. Arch Gen Psychiatry 57:1105-1114, 2000.
56. Mann JJ, Stoff DM. A synthesis of current findings regarding neurobiological correlates and treatment of suicidal behavior. Ann NY Acad Sci 836:352-363, 1997.
57. Malone KM, Mann JJ. Serotonin and major depression. In: Mann JJ, Kupfer DJ, eds. Biology of Depressive Disorders, Vol. 3, Part A: A System Perspective. New York: Plenum Press, 1993.
58. Mann JJ, Huang YY, Underwood MD, Kassir SA, Oppenheim S, Kelly TM, Dwork AJ, Arango V. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry 57:729-738, 2000.
59. Mann JJ, Brent DA, Arango V. The neurobiology and genetics of suicide and attempted suicide: a focus on the serotonergic system. Neuropsychopharmacology 24:467-477, 2001.
60. Nielsen DA, Goldman D, Virkkunen M, Tokola R, Rawlings R, Linnoila M. Suicidality and 5-hydro-xyindoleacetic acid concentration associated with a tryptophan hydroxylase polymorphism. Arch Gen Psychiatry 51:34-38, 1994.
61. Nielsen DA, Virkkunen M, Lappalainen J, Eggert M, Brown GL, Long JC, Goldman D, Linnoila M. A tryptophan hydroxylase gene marker for suicidality and alcoholism. Arch Gen Psychiatry 55:593-602, 1998.
62. Mann JJ, Malone KM, Nielsen DA, Goldman D, Erdos J, Gelertner J. Possible association of a polymorphism of the tryptophan hydroxylase gene with suicidal behavior in depressed patients. Am J Psychiatry 154:1451-1453, 1997.
63. Buresi C, Courtet P, Leboyer M, Feingold J, Malafosse A. Association between suicide attempt and the Trytophane Hydroxylase (TPH) gene. In: Forty-Seventh Annual Meeting of the American Society of Human Genetics, Baltimore, MD, October 28-November 1, 1997. (abstracts) Am J Hum Genet 61 Suppl: A270, 1997.
64. Persson M-L. Suicide Attempt and Genes. Psychiatric and Genetic Characteristics of Suicide Attempters. Stockholm: Kongl Karolinska Medico Chirurgiska Institutet, 1999.
65. Bellivier F, Leboyer M, Courtet P, Buresi C, Beaufils B, Samolyk D, Allilaire JF, Feingold J, Mallet J, Malafosse A. Association between the tryptophan hydroxylase gene and manic-depressive illness. Arch Gen Psychiatry 55:33-37, 1998.
66. Kunugi H, Ishida S, Kato T, Sakai T, Tatsumi M, Hirose T, Nanko S. No evidence for an association of polymorphisms of the tryptophan hydroxylase gene with affective disorders or attempted suicide among Japanese patients. Am J Psychiatry 156:774-776, 1999.
67. Ono H, Shirakawa O, Nishiguchi N, Nishimura A, Nushida H, Ueno Y, Maeda K. Tryptophan hydroxylase gene polymorphisms are not associated with suicide. Am J Med Genet 96:861-863, 2000.
68. Manuck SB, Flory JD, Ferrell RE, Dent KM, Mann JJ, Muldoon MF. Aggression and anger-related traits associated with a polymorphism of the tryptophan hydroxylase gene. Biol Psychiatry 45:603-614, 1999.
69. Joensson EG, Goldman D, Spurlock G, Gustavsson JP, Nielsen DA, Linnoila M, Owen MJ, Sedvall GC. Tryptophan hydroxylase and catechol-O-methyl-transferase gene polymorphisms: relationships to monoamine metabolite concentrations in CSF of healthy volunteers. Eur Arch Psychiatry Clin Neurosci 247:297-302, 1997.
70. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527-1531, 1996.
71. Stoltenberg SF, Burmeister M. Recent progress in psychiatric genetics—some hope but no hype. Hum Mol Genet 9:927-935, 2000.
72. Gorwood P, Batel P, Ades J, Hamon M, Boni C. Serotonin transporter gene polymorphisms, alcoholism, and suicidal behavior. Biol Psychiatry 48:259264, 2000.
73. Greenberg BD, McMahon FJ, Murphy DL. Serotonin transporter candidate gene studies in affective disorders and personality: promises and potential pitfalls. Mol Psychiatry 3:186-189, 1998.
74. Sher L. Psychiatric diagnoses and inconsistent results of association studies in behavioral genetics. Med Hypotheses 54:207-209, 2000.
75. Saudou F, Amara DA, Dierich A, Lemeur M, Ramboz S, Segu L, Buhot M-C, Hen R. Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science 265:1875-1878, 1994.
76. Crabbe JC, Phillips TJ, Feller DJ, Hen R, Wenger CD, Lessov, CN, Schafer GL. Elevated alcohol consumption in null mutant mice lacking 5-HT1B serotonin receptors. Nat Genet 14:98-101, 1996.
77. Ramboz S, Saudou F, Amara DA, Belzung C, Dierich A, Lemeur M, Segu L, Misslin R, Buhot MC, Hen R. Behavioral characterization of mice packing the 5-HT1B receptor. NIDA Res Monogr 161:3957, 1996.
78. Rocha BA, Ator R, Emmett-Oglesby MW, Hen R. Intravenous cocaine self-administration in mice lacking 5HT1B receptors. Pharmacol Biochem Behav 57:407-412, 1997.
79. Huang YY, Grailhe R, Arango V, Hen R, Mann JJ. Relationship of psychopathology to the human serotonin1B genotype and receptor binding kinetics in postmortem brain tissue. Neuropsychopharmacology 21:238-246, 1999.
80. Lappalainen J, Long JC, Eggert M, Ozaki N, Robin RW, Brown GL, Naukkarinen H, Virkkunen M, Linnoila M, Goldman D. Linkage of antisocial alcoholism to the serotonin 5HT1B receptor gene in 2 populations. Arch Gen Psychiatry 55:989-994, 1998.
81. Goldman D, Lappalainen J, Vallejo R, Robin RW, Virkkunen M, Linnoila M, Long J. Linkage of the 5HT1B serotonin receptor to antisocial alcoholism in Finns and Southwestern Indians (abstract). Am J Med Genet 81:479, 1998.
82. Zhang H-Y, Ishigaki T, Tani K, Chen K, Shih JC, Miyasato K, Ohara K. Serotonin2A receptor gene polymorphism in mood disorders. Biol Psychiatry 41:768-773, 1997.
83. Turecki G, Briere R, Dewar K, Antonetti T, Lesage AD, Seguin M, Chawky N, Vanier C, Alda M, Joober R, Benkelfat C, Rouleau GA. Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samplesfrom subjects who did or did not commit suicide. Am J Psychiatry 156:1456-1458, 1999.
84. Du L, Bakish D, Lapierre YD, Ravindran AV, Hrdina PD. Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder. Am J Med Genet 96:56-60, 2000.
85. Asberg M, Nordstrom P, Träskman-Bendz L. Cerebrospinal fluid studies in suicide. An overview. Ann NY Acad Sci 487:243-255, 1986.
86. Mann JJ, Oquendo M, Underwood MD, Arango V. The neurobiology of suicide risk: a review for the clinician. J Clin Psychiatry 60(uppl 2):7-11, 1999.
87. Oquendo MA, Mann JJ. The biology of impulsivity and suicidality. Psychiatr Clin North Am 23:11-25, 2000.
88. Cooper SJ, Kelly CB, King DJ. 5-Hydroxyindoleacetic acid in cerebrospinal fluid and prediction of suicidal behaviour in schizophrenia. Lancet 340:940-941, 1992.
89. Gardner DL, Lucas PB, Cowdry RW. CSF metabolites in borderline personality disorder compared with normal controls. Biol Psychiatry 28:247-254, 1990.
90. Van Praag HM. CSF 5HIAA and suicide in nondepressed schizophrenics. Lancet ii:977-978, 1983.
91. Ninan PT, Van Kammen DP, Scheinin M, Linnoila M Bunney WE Jr, Goodwin FK. CSF 5-hydroxyin-doleacetic acid levels in suicidal schizophrenic patients. Am J Psychiatry 141:566-569, 1984.
92. Drake RE, Gates C, Whitaker A, Cotton PG. Suicide among schizophrenics: a review. Compr Psychiatry 26:90-100, 1985.
93. Nordstrom P, Samuelsson M, Asberg M, Traskman-Bendz L, Aberg-Wistedt A, Nordin C, Bertilsson L. CSF 5HIAA predicts suicide risk after attempted suicide. Suicide Life Threat Behav 24(1):1-9, 1994.
94. Roy A, De Jong J, Linnoila M. Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. A 5-year follow-up study. Arch Gen Psychiatry 46:609-612, 1989.
95. Malone KM, Corbitt EM, Li S, Mann JJ. Prolactin response to fenfluramine and suicide attempt lethality in major depression. Br J Psychiatry 168:324-329, 1996.
96. Brown GL, Ebert MH, Goyer PF, Jimerson DC, Klein WJ, Bunney WE, Goodwin FK. Aggression, suicide, and serotonin: relationships to CSF amine metabolites. Am J Psychiatry 139:741-746, 1982.
97. Coccaro EF, Kavoussi RJ, Cooper TB, Hauger RL. Central serotonin activity and aggression: inverse relationship with prolactin response to d-fenflura-mine, but not CSF 5HIAA concentration, in human subjects. Am J Psychiatry 154:1430-1435, 1997.
98. Stahl SM. The human platelet. Diagnostic and research tool for the study of biogenic amines in psychiatric and neurologic disorders. Arch Gen Psychiatry 34:509-516, 1977.
99. Pandey GN. Altered serotonin function in suicide. Evidence from platelet and neuroendocrine studies. Ann NY Acad Sci 836:182-183, 1997.
100. Pandey GN, Pandey SC, Janicak PG, Marks RC, Davis JM. Platelet serotonin-2 receptor binding sites in depression and suicide. Biol Psychiatry 28:215-222, 1990.
101. Arango V, Underwood MD, Mann JJ. Postmortem findings in suicide victims: Implications for in vivo imaging studies. Ann NY Acad Sci 836:269-287, 1997.
102. Palmer AM, Lowe SL, Francis PT, Bowen DM. Are post-mortem biochemical studies of human brain worthwhile. Biochem Soc Trans 16:472-475, 1988.
103. Arango V, Ernsberger P, Marzuk PM, Chen J-S, Tierney H, Stanley M, Reis DJ, Mann JJ. Autoradiographic demonstration of increased serotonin 5-HT2 and ^-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry 47:1038-1047, 1990.
104. Hrdina PD, Demeter E, Vu TB, Sotonyi P, Palkovits M. 5HT uptake sites and 5HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala. Brain Res 614:37-44, 1993.
105. Mann JJ, Stanley M, McBride PA, McEwen BS. Increased serotonin2 and ^-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry 43:954-959, 1986.
106. Mann JJ, Underwood MD, Arango V. Postmortem studies of suicide victims. In: Watson SJ, ed. Biology of Schizophrenia and Affective Disease, 1st ed. Washington: American Psychiatric Press., 1996.
107. Stanley M, Mann JJ. Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet i:214-216, 1983.
108. Mann JJ, Kapur S. The emergence of suicidal ideation and behavior during antidepressant pharmacotherapy. Arch Gen Psychiatry 48:1027-1033, 1991.
109. Baldessarini RJ, Jamison KR. Effects of medical interventions on suicidal behavior. Summary and conclusions. J Clin Psychiatry 60(suppl 2):117-122, 1999.
110. Suicidal behavior and psychotropic medication. Accepted as a consensus statement by the ACNP Council, March 2, 1992. Neuropsychopharmacology 8:177-183, 1993.
111. Tondo L, Baldessarini RJ. Reduced suicide risk during lithium maintenance treatment. J Clin Psychiatry 61(suppl 9):97-104, 2000.
112. Coppen A. Lithium in unipolar depression and the prevention of suicide. J Clin Psychiatry 61(suppl 9):52-56, 2000.
113. Isometsa E, Henriksson M, Heikkinen M, Aro H, Lonnqvist J. Suicide and the use of antidepressants. Drug treatment of depression is inadequate. BMJ 308:915, 1994.
114. Oquendo MA, Malone KM, Ellis SP, Sackeim HA, Mann JJ. Inadequacy of antidepressant treatment for patients with major depression who are at risk for suicidal behavior. Am J Psychiatry 156:190-194, 1999.
115. Rutz W, Von Knorring L, Walinder J. Frequency of suicide on Gotland after systematic postgraduate education of general practitioners. Acta Psychiatr Scand 80:151-154, 1989.
116. Rihmer Z, Rutz W, Barsi J. Suicide rate, prevalence of diagnosed depression and prevalence of working physicians in Hungary. Acta Psychiatr Scand 88:391-394, 1993.
117. Isacsson G, Boethius G, and Bergman U. Low level of antidepressant prescription for people who later commit suicide: 15 years of experience from a population-based drug database in Sweden. Acta Psychiatr Scand 85:444-448, 1992.
118. Marzuk PM, Tardiff K, Leon AC, Stajic M, Morgan EB, Mann JJ. Prevalence of cocaine use among residents of New York City who committed suicide during a one-year period. Am J Psychiatry 149:371-375, 1992.
119. Isacsson G. Suicide prevention—a medical breakthrough? Acta Psychiatr Scand 102:113-117, 2000.
120. Meltzer HY. Suicide and schizophrenia: clozapine and the InterSePT study. International Clozaril/Leponex Suicide Prevention Trial. J Clin Psychiatry 60(suppl 12):47-50, 1999